Details for 2017700491

Up to date per 16.04.2026

Actions

Title / Product Name

VERFAHREN ZUR BEHANDLUNG VON CEA-POSITIVEN KARZINOMEN MIT PD-1-ACHSEN-BINDUNGSANTAGONISTEN UND BISPEZIFISCHEN ANTI-CEA/ANTI-CD3-ANTIKÖRPERN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2017700491

EP Publication Number

3400246

E-Number

1325776

Language

PCT Number

EP17050168

Publication Date

14.11.2018 A

21.10.2020 B1

Registration Date

21.10.2020

AT Publication Date

15.11.2020

Application Date

05.01.2017

Registration Number

Priorities

08.01.2016

16150506

IPC

C07K 16/30 20060101AFI20170804BHEP

Maximum Duration of Protection

05.01.2037

Owner

F. Hoffmann-La Roche AGGrenzacherstrasse 124 4070 BaselCH

Representative

No representatives present

Inventor

BACAC, Marinac/o Roche Glycart AG Wagistrasse 10 8952 SchlierenCH

COLOMBETTI, Sarac/o Roche Glycart AG Wagistrasse 10 8952 SchlierenCH

KLEIN, Christianc/o RocheGlycart AG Wagistrasse 10 8952 SchlierenCH

SAM, Johannesc/o Roche Glycart AG Wagistrasse 10 8952 SchlierenCH

SARO, Josec/o Roche Glycart AG Wagistrasse 10 8952 SchlierenCH

UMAÑA, Pabloc/o Roche Glycart AG Wagistrasse 10 8952 SchlierenCH